Considerations for inotrope and vasopressor use in critically ill patients with pulmonary arterial hypertension

SK Adie, AA Abdul-Aziz, SW Ketcham… - Journal of …, 2022 - journals.lww.com
Pulmonary arterial hypertension (PAH) is a rare and progressive cardiopulmonary disease,
characterized by pulmonary vasculopathy. The disease can lead to increase pulmonary …
被引用次数：3 相关文章

Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension.

SK Adie, AA Abdul-Aziz, SW Ketcham… - Journal of …, 2022 - europepmc.org
Pulmonary arterial hypertension (PAH) is a rare and progressive cardiopulmonary disease,
characterized by pulmonary vasculopathy. The disease can lead to increase pulmonary …

Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension

SK Adie, AA Abdul-Aziz, SW Ketcham… - Journal of …, 2022 - journals.lww.com
Pulmonary arterial hypertension (PAH) is a rare and progressive cardiopulmonary disease,
characterized by pulmonary vasculopathy. The disease can lead to increase pulmonary …

Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension

SK Adie, AA Abdul-Aziz… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Pulmonary arterial hypertension (PAH) is a rare and progressive cardiopulmonary disease,
characterized by pulmonary vasculopathy. The disease can lead to increase pulmonary …

Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension

SK Adie, AA Abdul-Aziz, SW Ketcham… - Journal of …, 2022 - ingentaconnect.com
Pulmonary arterial hypertension (PAH) is a rare and progressive cardiopulmonary disease,
characterized by pulmonary vasculopathy. The disease can lead to increase pulmonary …